Insitro
Medium RiskHealthcare
AI-powered drug discovery company using machine learning and biological data to develop new medicines.
5
Risk Score
(1-10 scale)
Data Handling
Storage Location
US servers
Retention Policy
Indefinite for research
Training on User Data
Yes, biological and patient data
Risk Factors
- ⚠Patient-derived biological data used in AI
- ⚠Long-term data retention for drug development
- ⚠Pharma partnership data sharing
Security Recommendations
- ✓Review biological sample consent terms
- ✓Understand data use in drug development
- ✓Monitor regulatory compliance
Compliance
SOC 2✓
GDPR✓
HIPAA✗
Manage This Tool
Automatically monitor and control Insitro usage in your organization
Get Aona AICompare Tools
See how Insitro stacks up against alternatives
Compare ToolsOther Healthcare Tools
12 Sigma Technologies
Risk: 7/10
AI-powered lung CT analysis platform for nodule detection.
Abridge
Risk: 7/10
AI platform that summarizes medical conversations into structured clinical notes.
Abridge AI
Risk: 6/10
AI medical conversation platform that summarizes doctor-patient conversations into structured clinical notes.